Liu, L., Liao, D., Wang, W., Xie, W., Xu, J., Zhang, Y., Zhou, F., Mei, H. (2025). Inotuzumab ozogamicin vs blinatumomab bridging optimization and second CD19 CAR-T efficacy in Relapsed/Refractory B-ALL. Blood. https://doi.org/10.1182/blood-2025-2398